127 related articles for article (PubMed ID: 34852131)
1. Antiparasitic and immunomodulating effects of nitazoxanide, ivermectin and selenium on Cryptosporidium infection in diabetic mice.
Fahmy MA; Abdelaal AA; Hassan SI; Shalaby MA; Ismail MAM; Khairy RA; Badawi MA; Afife AA; Fadl HO
Rev Bras Parasitol Vet; 2021; 30(4):e012121. PubMed ID: 34852131
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
Schnyder M; Kohler L; Hemphill A; Deplazes P
Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
[TBL] [Abstract][Full Text] [Related]
3. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
[TBL] [Abstract][Full Text] [Related]
4. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
[TBL] [Abstract][Full Text] [Related]
5. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
[No Abstract] [Full Text] [Related]
6. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
Abdou AG; Harba NM; Afifi AF; Elnaidany NF
Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
[TBL] [Abstract][Full Text] [Related]
7. Nitazoxanide, Ivermectin, and Artemether effects against cryptosporidiosis in diabetic mice: parasitological, histopathological, and chemical studies.
El-Ashkar AM; Mahmoud S; Sabry H; Guirguis N; El Komi W; Ali E; Abu Shousha T; Abdelmksoud HF
J Parasit Dis; 2022 Dec; 46(4):1070-1079. PubMed ID: 36092469
[TBL] [Abstract][Full Text] [Related]
8.
Gattan HS; Wakid MH; Qahwaji RM; Altwaim S; Mahjoub HA; Alfaifi MS; Elshazly H; Al-Megrin WAI; Alshehri EA; Elshabrawy HA; El-Kady AM
Front Vet Sci; 2024; 11():1374116. PubMed ID: 38515537
[TBL] [Abstract][Full Text] [Related]
9. ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
Abaza BE; Hamza RS; Farag TI; Abdel-Hamid MA; Moustafa RA
J Egypt Soc Parasitol; 2016 Dec; 46(3):683-692. PubMed ID: 30230765
[TBL] [Abstract][Full Text] [Related]
10. Eugenol: effective complementary treatment for cryptosporidiosis in experimentally infected mice.
Gattan HS; Fouad SS; Ellisy RA; Elshazly H; El-Kady AM
J Parasit Dis; 2024 Jun; 48(2):370-380. PubMed ID: 38840881
[TBL] [Abstract][Full Text] [Related]
11. Role of wheat germ agglutinin (WGA) in treatment of experimental cryptosporidiosis.
Moustafa MA
J Egypt Soc Parasitol; 2003 Aug; 33(2):443-56. PubMed ID: 14964659
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
Madbouly Taha N; Salah A Yousof HA; El-Sayed SH; Younis AI; Ismail Negm MS
Exp Parasitol; 2017 Oct; 181():57-69. PubMed ID: 28764965
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic changes in the intestinal epithelium of
Hassan ZR; Salama DEA; Ibrahim HF
J Parasit Dis; 2022 Dec; 46(4):1011-1020. PubMed ID: 36457780
[No Abstract] [Full Text] [Related]
14. Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.
Moawad HSF; Hegab MHAE; Badawey MSR; Ashoush SE; Ibrahim SM; Ali AAES
J Parasit Dis; 2021 Sep; 45(3):606-619. PubMed ID: 34475640
[TBL] [Abstract][Full Text] [Related]
15. Dual mechanism (sunlight/dark) of the self-assembly nitazoxanide drug on cellulose nanocrystal surface for destroying the Cryptosporidium parvum oocysts.
Khaleil SR; Mira NM; Ghanem NF; M El-Mehasseb I; Helal IB; El-Shafai NM
Int J Biol Macromol; 2023 Aug; 247():125823. PubMed ID: 37453638
[TBL] [Abstract][Full Text] [Related]
16. Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have
Bartelt LA; Bolick DT; Kolling GL; Stebbins E; Huston CD; Guerrant RL; Hoffman PS
Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297368
[No Abstract] [Full Text] [Related]
17. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
[TBL] [Abstract][Full Text] [Related]
18. Secondary and primary murine alveolar echinococcosis: combined albendazole/nitazoxanide chemotherapy exhibits profound anti-parasitic activity.
Stettler M; Rossignol JF; Fink R; Walker M; Gottstein B; Merli M; Theurillat R; Thormann W; Dricot E; Segers R; Hemphill A
Int J Parasitol; 2004 Apr; 34(5):615-24. PubMed ID: 15064126
[TBL] [Abstract][Full Text] [Related]
19. Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model.
Blagburn BL; Drain KL; Land TM; Kinard RG; Moore PH; Lindsay DS; Patrick DA; Boykin DW; Tidwell RR
Antimicrob Agents Chemother; 1998 Nov; 42(11):2877-82. PubMed ID: 9797219
[TBL] [Abstract][Full Text] [Related]
20. Newly fabricated zinc oxide nanoparticles loaded materials for therapeutic nano delivery in experimental cryptosporidiosis.
Hamdy DA; Ismail MAM; El-Askary HM; Abdel-Tawab H; Ahmed MM; Fouad FM; Mohamed F
Sci Rep; 2023 Nov; 13(1):19650. PubMed ID: 37949873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
